Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Novartis
Orano Med LLC
National Cancer Institute (NCI)
Amgen
Instituto do Cancer do Estado de São Paulo
National Institutes of Health Clinical Center (CC)
Vastra Gotaland Region
Fundación de investigación HM
Rezolute
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Providence Health & Services
National Cancer Institute (NCI)
RayzeBio, Inc.
Melanoma and Skin Cancer Trials Limited
National Health Research Institutes, Taiwan
National Institutes of Health Clinical Center (CC)
ITM Solucin GmbH
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Turning Point Therapeutics, Inc.
National Institutes of Health Clinical Center (CC)
RayzeBio, Inc.
Boston Scientific Corporation
Melanoma and Skin Cancer Trials Limited
National Institutes of Health Clinical Center (CC)
Legend Biotech USA Inc
Exelixis
University Health Network, Toronto
M.D. Anderson Cancer Center
Crinetics Pharmaceuticals Inc.
University of Wisconsin, Madison
Centre Oscar Lambret
Stanford University
University of California, San Francisco
M.D. Anderson Cancer Center
Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc.
M.D. Anderson Cancer Center
Hoffmann-La Roche
Grupo Espanol de Tumores Neuroendocrinos
University of Michigan Rogel Cancer Center
Columbia University
Emory University
Eisai Inc.
Olivia Newton-John Cancer Research Institute